FGF1 and Hyperglycemia: When icv FGF1 injection was combined with continuous SHU9119 infusion, however, remission of hyperglycemia was not sustained even though the transient effects of icv FGF1 to reduce food intake, BW, and BG levels remained intact (Fig. 6c; Supplementary Fig. 6).